echoloc

HistoSonics, Inc. Tech Stack

Focused ultrasound platform for non-invasive tissue ablation

Medical Equipment Manufacturing Plymouth, Minnesota 201–500 employees Founded 2009 Privately Held

HistoSonics develops histotripsy—a sonic beam therapy using focused ultrasound to destroy targeted tissue without incisions or thermal damage. The stack is medical-device heavy: embedded Linux (Yocto, Buildroot), NVIDIA edge compute, Azure/AWS cloud infrastructure, and HL7/FHIR for clinical integration. Sales hiring (11 roles) outpaces engineering (8), reflecting a mature product moving into market expansion; concurrent pain points around reimbursement, clinical adoption, and workflow integration suggest the commercialization phase is constraint-bound by payer and provider processes, not engineering velocity.

Tech Stack 25 technologies

Core StackAWS SQL Server DocuSign Jira Azure DevOps Playwright Selenium Cypress C# Java Windows Embedded Configuration Manager Windows PE ISO 27001 Yocto Ubuntu Buildroot NVIDIA Jetson HL7 FHIR Azure ADP Workforce Now Azure IoT Edge Azure Arc Ranorex

What HistoSonics, Inc. Is Building

Challenges

  • Workflow integration challenges
  • Reimbursement challenges
  • Clinical implementation adoption
  • Clinical adoption of new technology
  • Procedural growth
  • Expanding commercial sales
  • Clinical implementation challenges
  • Expanding into new indications
  • Economic adoption barriers
  • Coverage and payment challenges

Active Projects

  • Clinical and technical product demonstrations
  • Procedural launches
  • Edison system security controls implementation
  • Clinical implementation of edison® system
  • Program development
  • New site launches
  • Technology integrations
  • Post sales installation and adoption protocol
  • Capital equipment sales cycle
  • Clinical advisory board planning

Hiring Activity

Accelerating35 roles · 25 in 30d

Department

Sales
11
Healthcare
9
Engineering
8
Product
2
Support
2
Manufacturing
1
Research
1

Seniority

Manager
13
Senior
12
Mid
7
Director
1
Principal
1
Company intelligence

Find more companies like HistoSonics, Inc. by tech stack, pain points and active projects

Get started free

About HistoSonics, Inc.

HistoSonics is a medical-device manufacturer founded in 2009, based in Plymouth, Minnesota with offices in Ann Arbor, Madison, and Minneapolis. The company commercializes the Edison System, a focused ultrasound platform for interventional procedures. The business model is capital equipment sales (multi-step sales cycles) paired with clinical implementation support and post-install adoption services. Active projects span procedural launches, new site onboarding, clinical advisory engagement, and technology integrations with hospital workflows. The organization is scaling sales and clinical teams faster than engineering, and is now hiring in Singapore alongside the US, signaling geographic expansion.

HeadquartersPlymouth, Minnesota
Company Size201–500 employees
Founded2009
Hiring MarketsUnited States, Singapore

Frequently Asked Questions

What tech stack does HistoSonics use?

Embedded systems (Windows Embedded, Yocto, Buildroot, Ubuntu), NVIDIA Jetson edge compute, Azure and AWS cloud, SQL Server, HL7/FHIR healthcare protocols, Azure IoT Edge and Arc, plus test automation (Selenium, Playwright, Cypress, Ranorex) and development tools (Jira, Azure DevOps, C#, Java).

Where is HistoSonics headquartered?

Plymouth, Minnesota. Additional offices in Ann Arbor, Michigan; Madison, Wisconsin; and active hiring expansion into Singapore.

Similar Companies in Medical Equipment Manufacturing

Other companies in the same industry, closest in size

How this profile is built

HistoSonics, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.